References
- Basedow, L. A., Kuitunen-Paul, S., Eichler, A., Roessner, V., & Golub, Y. (2021). Diagnostic accuracy of the Drug Use Disorder Identification Test (DUDIT) and its short form, the DUDIT-C, in German adolescent psychiatric patients. Frontiers in Psychology, 12, 2108. https://doi.org/10.3389/fpsyg.2021.678819
- Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2002). Drug Use Disorders Identification Test
- Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2005). Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research, 11(1), 22–31. https://doi.org/10.1159/000081413
- Butzner, M., & Cuffee, Y. (2021). Telehealth interventions and outcomes across rural communities in the United States: Narrative review. Journal of Medical Internet Research, 23(8), e29575. https://doi.org/10.2196/29575
- Cantor, J. H., McBain, R. K., Pera, M. F., Bravata, D. M., & Whaley, C. M. (2021). Who is (and is not) receiving telemedicine care during the COVID-19 pandemic. American Journal of Preventive Medicine, 61(3), 434–438. https://doi.org/10.1016/j.amepre.2021.01.030
- Lin, L., Casteel, D., Shigekawa, E., Weyrich, M. S., Roby, D. H., & McMenamin, S. B. (2019). Telemedicine-delivered treatment interventions for substance use disorders: A systematic review. Journal of Substance Abuse Treatment, 101, 38–49. https://doi.org/10.1016/j.jsat.2019.03.007
- Mark, T. L., Treiman, K., Padwa, H., Henretty, K., Tzeng, J., & Gilbert, M. (2022). Addiction treatment and telehealth: Review of efficacy and provider insights during the COVID-19 pandemic. Psychiatric Services (Washington, D.C.), 73(5), 484–491. https://doi.org/10.1176/appi.ps.202100088
- Pape, H., Lobmaier, P., & Bukten, A. (2022). An evaluation of eight short versions of the Drug Use Disorder Identification Test (DUDIT). A prison population study. Drug and Alcohol Dependence Reports, 3, 100043. https://doi.org/10.1016/j.dadr.2022.100043
- Substance Abuse and Mental Health Services Administration (SAMHSA). (2021). Telehealth for the treatment of serious mental illness and substance use disorders. SAMHSA Publication No. PEP21-06-02-001. National Mental Health and Substance Use Policy Laboratory. Substance Abuse and Mental Health Services Administration.
- Ward, M. M., Fox, K., Merchant, K., et al. (2020). Measure and Data Element Identification for the HRSA Evidence-Based Tele-Behavioral Health Network Program and the HRSA Substance Abuse Treatment Telehealth Network Grant Program. Rural Telehealth Research Center. Research & Policy Brief. April.